Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels

Anna Wonnerth(Medical University of Vienna), Thomas W. Weiss(University of Vienna), Johann Wojta(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Katharina M. Katsaros(Medical University of Vienna), Ingebjørg Seljeflot(Oslo University Hospital), Kurt Huber(Sigmund Freud Privatuniversität Wien), Harald Arnesen(Oslo University Hospital), Christoph Kaun(University of Vienna), Konstantin A. Krychtiuk(Ludwig Boltzmann Institute for Cardiovascular Research), Kylie Thaler(Medical University of Vienna), Walter S. Speidl(University of Applied Sciences St Pölten)
Metabolism
February 14, 2014
10.1016/j.metabol.2014.02.005
Cited by 14

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755